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Abstract
Background:  Proximal 22q is rich in low copy repeats (LCRs) which mediate non-allelic
homologous recombination and give rise to deletions and duplications of varying size depending on
which LCRs are involved.
Methods: A child with multiple septal defects and other congenital anomalies was investigated for
genome imbalance using multiplex ligation-dependent probe amplification (MLPA) for
subtelomeres and microdeletion loci, followed by array comparative genomic hybridization (CGH)
using oligonucleotide arrays with 44,000 probes across the genome.
Results: MLPA identified a single probe deletion in the SNAP29 gene within band 22q11.21.
Follow-up array CGH testing revealed a ~1.4-Mb deletion from 19,405,375 bp to 20,797,502 bp,
encompassing 28 genes.
Conclusion:  This deletion is likely to be causally associated with the proband's congenital
anomalies. Previous publications describing deletions in proximal 22q have reported deletions
between LCRs 1 to 4, associated with 22q11 deletion syndrome; in addition, deletions between
LCRs 4 and 6 have been described associated with "distal 22q11 deletion syndrome". To our
knowledge, this is the first deletion which spans LCR4 and is not apparently mediated by LCRs.
Comparison of the phenotypes found in conjunction with previously reported deletions, together
with the function and expression patterns of genes in the deleted region reported here, suggests
that haploinsufficiency for the Crk-like (CRKL) gene may be responsible for the reported cardiac
abnormalities.
Background
The proximal region of the chromosome 22 long arm is
rich in low copy repeats (LCRs), which are known to
mediate non-allelic homologous recombination
(NAHR)[1]. The most common of these events is the
recombination between LCRs 2 and 4, which gives rise to
a 3-megabase (Mb) deletion, associated with chromo-
some 22q11 deletion syndrome (which includes features
of Velocardiofacial syndrome and DiGeorge syn-
drome)[2]. The reciprocal duplication event gives rise to
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milder but similar features[3,4]. Until recently, these
reciprocal events were thought to be underdetected, as
theoretically they should occur at the same frequency as
the deletion. However, Turner et al have shown, based on
modeling of the deletion/duplication, that the deletion
events are likely to be more prevalent[5]. The 1.5-Mb dele-
tion that occurs following NAHR between LCRs 2 and 3 is
associated with similar features to those found in individ-
uals with the 3-Mb deletion[6].
A number of studies of individuals with dysmorphism
and/or developmental delay has revealed a cluster of dele-
tions distal to LCR4, the distal end of the common 3 Mb
deletion [7-10]. The patients described in these papers
have a range of phenotypic features, which are not found
associated with the more proximal deletions. In this paper
we describe a patient with an atypical deletion spanning
LCR4, and compare her features with those found in over-
lapping deletions.
Case presentation
Clinical details
The patient is the first child born in this relationship to
healthy non-consanguineous parents and her father has an
older child who is healthy. Her mother (150 cm in height)
is Caucasian and her father (180 cm) is half Maltese.
During the pregnancy, bowel problems were suspected
after a routine week 13 ultrasound scan was abnormal.
She was delivered at 36 and a half weeks by lower segment
cesarean section in response to her failure to progress; her
birth weight was 1.76 kg with symmetrical growth retarda-
tion, and a head circumference of 28.5 cm At birth she was
found to have multiple septal defects (both atrial and ven-
tricular – ASDs and VSDs), two of which have been
patched surgically and two are being observed with the
expectation that they will close spontaneously. She had an
imperforate anus (with no fistula) requiring a colostomy,
which was reversed when she was 18 months old. Apart
from microcephaly, brachycephaly and slight clinodactyly
of the right 5th finger she did not have any dysmorphic fea-
tures and there was no evidence of asymmetry. Her length
was first measured at 17 weeks (13 weeks corrected for
prematurity) and was 54 cm.
Postnatally she continued to demonstrate growth failure,
with height and weight consistently on or just below the
0.4th centile, and her head circumference is growing well
below the 0.4th centile. The relative proportions of her
head circumference, height and weight have not changed
with time. Other areas of development are causing no
concerns.
Methods
G-banded chromosome analysis was carried out on cul-
tured peripheral lymphocytes, using standard laboratory
techniques. Multiplex ligation-dependent probe amplifi-
cation (MLPA; MRC Holland) was carried out using kits
for the subtelomere regions of every chromosome (P036B
and P069), and a kit for the common microdeletion loci
(P245). Array comparative genomic hybridization (array
CGH) used oligonucleotide arrays containing approxi-
mately 44,000 probes across the genome (Agilent). The
proband's DNA was labeled with two different fluoro-
chromes, then co-hybridized with two other patients'
DNA, differentially labeled, to give a "dye swap" and
hence added confidence in the results.
Results
Standard karyotype analysis and MLPA testing with
probes for the subtelomere regions did not detect any
abnormality. However, MLPA with probes for the com-
mon microdeletion loci revealed an apparent deletion in
the SNAP29 gene. This gene lies at the distal end of the
common 3-Mb 22q11 deletion interval. All other, more
proximal, probes in this region showed normal copy
number. MLPA testing of both parents showed that this
finding was de novo in the proband, and therefore unlikely
to be caused by an inherited single nucleotide polymor-
phism (SNP) at the ligation site of the MLPA probe.
Although a balanced insertional translocation in one of
the parents has not been specifically excluded, it is consid-
ered most likely that the deletion in the proband arose as
a result of crossing over between LCRs (see below), the
mechanism for submicroscopic interstitial deletions in
most cases.
Array CGH was therefore carried out and showed an
approximately 1.5-Mb deletion (minimum 19,405,634 –
20,797,302 and maximum 19,288,984 – 20,834,070 bp
from the chromosome 22 short arm telomere), contain-
ing approximately 28 genes. Figure 1 shows the deletion
breakpoints and the genomic region around the deletion.
Discussion
Previous papers have described "atypical" deletions distal
to the common 3-Mb deletion associated with DiGeorge/
Velocardiofacial syndrome [7-10] (see Figure 1). The
patients described in these papers have relatively mild
phenotypes, with few common features. The deletions
described all end within LCRs, which are thought to medi-
ate the deletion events via NAHR. A further paper[11]
describes a patient with a deletion apparently extending
from within the common 3-Mb deletion interval to a
locus distal to LCR4. However, close inspection of the
data reveals that there are no informative markers beyond
LCR4 for this patient, and the published figure in fact rep-
resents the maximum deleted region. There is no evidence
for deletion beyond LCR4 for this patient.
The patient described in the current work is apparently
unique in having a deletion which spans LCR4, the distalMolecular Cytogenetics 2009, 2:9 http://www.molecularcytogenetics.org/content/2/1/9
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Deletion breakpoints and the genomic region around the deletion Figure 1
Deletion breakpoints and the genomic region around the deletion.
Ben-Shachar8
LCR4 (LCRD)
LCR3
Garcia-Miñaur18
Rauch7, Mikhail9, Saitta10
LCR6
LCR5
“common” 3-Mb deletion
LCR2
Table 1: Phenotype of patients with "atypical" 22q11 distal deletions
Garcia-Minaur18
LCR30–LCR4
~1.5 Mb
microsats/FISH
1 case (pat)
Our case
~1.4 Mb
oligo array
Ben Shachar8
LCR4–LCR5 
~1.4 Mb 
BAC arrays
4 Cases
Saitta10
LCR4–LCR6
~2.1 Mb
cosmid FISH
1 case
Ben Shachar8
LCR4–LCR6 
~2.1 Mb
BAC arrays 
2 Cases
Rauch7
LCR4–LCR6
~2.1 Mb
FISH/PCR
1 case
Mikhail9
LCR4–LCR6
1.55–1.92 Mb
BAC arrays 
1 case
Cardiac defect TOF VSD+ASD 1/4 bicuspid aortic 
valve
VSD+ truncus 
arteriosus
1-/2 truncus 
arteriosus
VSD -
bifid uvula +
cleft palate - 1/2
short stature + +
microcephaly + +
hypoplastic nasal 
alae
3/4 + 1/2
smooth philtrum + + +
dev delay 3/4 +
arched eyebrows 2/4 + +Molecular Cytogenetics 2009, 2:9 http://www.molecularcytogenetics.org/content/2/1/9
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point of the common deleted region, and the proximal
point of many of the "atypical" distal deletions. Her phe-
notype may therefore shed light on the relative role of the
genes around LCR4 in contributing to the features associ-
ated with these deletions. The breakpoints of this deletion
do not correspond to any of the major LCRs found on
chromosome 22. However, we have identified a 3.7-kb
block of high (97%) similarity between the two break-
point regions – this is 19,351,886–19,355,637 in the
proximal breakpoint region and 20,799,044–20,802,748
in the distal breakpoint region. This homology may pro-
vide the mechanism for this novel deletion.
Table 1 shows the phenotypic features found in the pub-
lished cases, and in the case described here. Only cardiac
defects and other features found in more than one indi-
vidual are included.
This region contains 28 obvious gene-like items (see Addi-
tional file 1). Of these, the following are either pseudo-
genes or are one of several copies – MGC16703 (tubulin
pseudogene), RBP3.2, RBP3.3 (two of the three copies are
deleted here), PI4KAP2 (probable pseudogene of
PIKA4CA, also deleted here), GGT2 (primate-specific
duplication of GGT1). This leaves 23, of which 21 are pro-
tein-coding and 2 are miRNA-encoding. Of these, three
are unlikely candidates for the cardiac anomalies, as there
are reported knock-out mice with no reported cardiac
phenotype or heterozygote phenotype (UBE2L3[12],
MAPK1/ERK2[13], TOP3B[14]) and one (SNAP29) is
unlikely because null mutations in humans yield a reces-
sive condition with no cardiac component[15]. Other
genes range from known functions which are hard to con-
nect with the phenotype, to completely unknown func-
tion; only circumstantial considerations (e.g. expression
profiles, often in adult tissues) can be used to rule them in
or out.
The strongest candidate, however, is CRKL. This has a
highly relevant knock-out mouse phenotype: crkl-/- mice
die in utero with cranial nerve and aortic defects and
100% have VSD with overriding aortic arch, and may also
have defective thymus, thyroid and parathyroid[16]. The
heterozygote mouse (crkl+/-) only has craniofacial and/or
thymic defects, but when combined with heterozygosity
for tbx1, DGS-like heart defects are seen[17]. Haploinsuf-
ficient effects are notoriously strain- and species-depend-
ent, so it seems likely that the CRKL+/- state in humans
could give some of the defects seen in the crkl+/-;tbx1+/-
mouse, which could be quite variable between individu-
als. The heart defects seen in our patient may therefore be
due to haploinsufficiency of this gene; the position of the
CRKL gene proximal to LCR4 means that our patient's car-
diac defects could be regarded as a subset of the defects
found in "classic DGS". As there are no consistent pheno-
typic differences between LCR2-4 and LCR2-3 DGS cases,
the effects of CRKL+/-, although substantial on their own,
may be masked by TBX1+/-. Garcia-Miñaur et al[18] in
their paper describing a LCR3-4 deletion, also suggest
CRKL as a candidate gene for the cardiac defects found in
their patient. The deletion interval we describe thus pro-
vides a tighter focus on this gene, with the caveat that our
patient shows only septal defects, rather than the Tetral-
ogy of Fallot found by Garcia-Miñaur.
Table 1 shows that cardiac defects have been found in 4
other individuals who have more distal deletions, and are
therefore not haploinsufficient for CRKL, indicating that
there are likely to be other cardiac-related genes distal to
LCR4. However, in the absence of obvious candidates for
these genes in the region of overlap between our patient
and the patients with deletions distal to LCR4, these other
genes are likely to lie beyond the distal breakpoint in our
patient. Apart from growth retardation leading to short
stature and disproportionate microcephaly, and very
minor dysmorphisms, there are no features shared by our
patient and the others described with deletions distal to
LCR4. The genes in the common deletion interval may
therefore be copy number-independent, or have variable
penetrance.
Conclusion
In conclusion, although the possibility remains that one
or more of the genes in our patient's deleted interval distal
to LCR4 may be responsible for her cardiac defects, this
case has provided evidence for a role for haploinsuffi-
ciency of CRKL in abnormalities of cardiac development.
Further studies investigating the status of this gene in
patients with microcephaly in association with septal
defects or Tetralogy of Fallot may provide further evidence
of this causal link.
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